Earnings Per Share (EPS): 7.49
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 7.49 is in line with its 5-year average of 7.17, around the middle of its 5-year range (4.68–8.90).
As of Saturday, June 27, 2026. 10.31% above its 12-month average of 6.79.
WST Earnings Per Share (EPS)
Reported quarterly EPS; no daily interpolation.
WST Quarterly EPS Growth (YoY)
EPS growth vs the same quarter one year earlier, last 20 quarters.
WST Average Earnings Per Share (EPS) Chart
WST Current vs Average Earnings Per Share (EPS) Chart
WST Earnings Per Share (EPS) Metrics
EARNINGS PER SHARE (EPS)
7.49
EARNINGS PER SHARE (EPS) AVG TTM
6.79
EARNINGS PER SHARE (EPS) AVG 3Y
7.36
EARNINGS PER SHARE (EPS) AVG 5Y
7.17
EARNINGS PER SHARE (EPS) AVG 10Y
4.95
EARNINGS PER SHARE (EPS) AVG 15Y
3.82
EARNINGS PER SHARE (EPS) AVG 20Y
3.16
CURRENT VS TTM AVG
+10.31%
CURRENT VS 3Y AVG
+1.73%
CURRENT VS 5Y AVG
+4.44%
CURRENT VS 10Y AVG
+51.37%
CURRENT VS 15Y AVG
+96.07%
CURRENT VS 20Y AVG
+136.74%
WST Competitors' Earnings Per Share (EPS)
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | $24.79B | 7.49 | 6.79 | 7.36 | 7.17 |
| Waters Corporation (WAT)vs › | $24.41B | 7.87 | 10.78 | 11.05 | 10.65 |
| Mettler-Toledo International Inc. (MTD)vs › | $25.54B | 42.71 | 41.42 | 39.43 | 36.04 |
| Quest Diagnostics Incorporated (DGX)vs › | $23.08B | 9.05 | 8.33 | 8.09 | 9.83 |
| BioNTech SE (BNTX)vs › | $23.07B | -5.94 | -4.08 | 9.21 | 14.48 |
| United Therapeutics Corporation (UTHR)vs › | $23.03B | 27.05 | 28.29 | 23.40 | 19.31 |
| Moderna, Inc. (MRNA)vs › | $26.69B | -8.15 | -8.27 | -1.90 | 3.46 |
| Incyte Corporation (INCY)vs › | $22.73B | 7.08 | 3.38 | 2.74 | 2.31 |
| DexCom, Inc. (DXCM)vs › | $27.07B | 2.34 | 1.80 | 1.48 | 1.30 |
| Labcorp Holdings Inc. (LH)vs › | $22.26B | 11.29 | 9.71 | 9.57 | 13.14 |
EPS Comparison
Trailing EPS (TTM)
$7.49
Forward EPS (Est.)
$9.58
P/E Ratio
46.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
- Directly impacts stock valuation through P/E ratio
- Used to calculate dividend coverage and payout ratios
- Enables comparison across companies of different sizes
- Growth in EPS often correlates with stock price appreciation
Earnings Per Share (EPS) Formula & Definition
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Earnings Per Share (EPS) FAQ
- What is the earnings per share (EPS) for West Pharmaceutical Services, Inc. (WST)?
- The earnings per share (EPS) for WST stock is 7.49.
- Is West Pharmaceutical Services, Inc.'s earnings per share (EPS) high or low?
- The earnings per share (EPS) of 7.49 is in line with its 5-year average of 7.17, around the middle of its 5-year range (4.68–8.90).
- What is the TTM average earnings per share (EPS) for West Pharmaceutical Services, Inc. (WST)?
- The TTM average earnings per share (EPS) for WST stock is 6.79.
- What is the 3Y average earnings per share (EPS) for West Pharmaceutical Services, Inc. (WST)?
- The 3Y average earnings per share (EPS) for WST stock is 7.36.
- What is the 5Y average earnings per share (EPS) for West Pharmaceutical Services, Inc. (WST)?
- The 5Y average earnings per share (EPS) for WST stock is 7.17.
- What is the 10Y average earnings per share (EPS) for West Pharmaceutical Services, Inc. (WST)?
- The 10Y average earnings per share (EPS) for WST stock is 4.95.
- What is the 15Y average earnings per share (EPS) for West Pharmaceutical Services, Inc. (WST)?
- The 15Y average earnings per share (EPS) for WST stock is 3.82.
- What is the 20Y average earnings per share (EPS) for West Pharmaceutical Services, Inc. (WST)?
- The 20Y average earnings per share (EPS) for WST stock is 3.16.
WST Earnings Per Share (EPS) History
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 6.83 |
| 2024-12-31 | 6.75 |
| 2023-12-31 | 7.99 |
| 2022-12-31 | 7.88 |
| 2021-12-31 | 8.90 |
| 2020-12-31 | 4.68 |
| 2019-12-31 | 3.27 |
| 2018-12-31 | 2.80 |
| 2017-12-31 | 2.04 |
| 2016-12-31 | 1.96 |
| 2015-12-31 | 1.33 |
| 2014-12-31 | 1.79 |
| 2013-12-31 | 1.61 |
| 2012-12-31 | 1.19 |
| 2011-12-31 | 1.12 |
| 2010-12-31 | 0.98 |
| 2009-12-31 | 1.11 |
| 2008-12-31 | 1.33 |
| 2007-12-31 | 1.08 |
| 2006-12-31 | 1.05 |
| 2005-12-31 | 0.75 |
| 2004-12-31 | 0.57 |
| 2003-12-31 | 0.75 |
| 2002-12-31 | 0.33 |
| 2001-12-31 | -0.09 |
| 2000-12-31 | 0.03 |
| 1999-12-31 | 0.65 |
| 1998-12-31 | 0.10 |
| 1997-12-31 | 0.67 |
| 1996-12-31 | 0.25 |
Related Metrics
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Eric Green